Endo Tools Therapeutics Secures $23 million in Series C Financing to Advance The endomina® technology and Commercialization of New endomina EZFuse System

Endo Tools Therapeutics Secures $23 million in Series C Financing to Advance The endomina® technology and Commercialization of New endomina EZFuse System Funding to accelerate U.S., European and Middle East commercialization and collect clinical evidence for U.S. weight loss marketing indication Gosselies, Belgium – July 16th, 2026 – Endo Tools Therapeutics (ETT), developers of advanced […]

Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation Endomina® EZFuse system 

Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation Endomina® EZFuse system   510(k) clearance enables immediate U.S. commercialization of enhanced soft tissue approximation technology in the gastrointestinal tract   Gosselies, Belgium – March 17, 2026 – Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices, today announced that the U.S. Food and Drug Administration (FDA) has […]

Please confirm your location. Content for healthcare professionals only.

Europe and Middle East
US